Approved PLCO Projects
Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Pan-cancer genome-wide association study of tissue disruption phenotypes on standard histologic images from PLCO | Mustapha Abubakar | Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, USA | PLCO | Mar 8, 2023 | PLCOI-1172 |
| Reduced rank regression derived dietary patterns and risk of colorectal cancer and mortalit | zegeye Abitew | Flinders University, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Adelaide, South Australia | PLCO | Feb 27, 2023 | PLCO-1166 |
| The Use of Machine Learning to predict if patients with Renal Cancer will surivive or not | Vineel Ramineni | Academies of Loudoun | PLCO | Feb 27, 2023 | PLCO-1169 |
| Blood-based biomarkers for risk assessment and early detection of colorectal cancers | Samir Hanash | University of Texas MD Anderson Cancer Center | PLCO | Feb 23, 2023 | 2022-0046 |
| Carcinikos - Presentiment of Cancer in Male using multi modal techniques | Ananthanagu U | PES University | PLCO | Feb 21, 2023 | PLCO-1168 |
| Phenome-Wide Association Studies of the immune-related genetic variants | Feng Chen | Nanjing Medical University | PLCO | Feb 14, 2023 | PLCO-1165 |
| Instrumental Variables Methods Reconcile Disparate Intention-to-Treat Effects Across Pragmatic Trials | Joshua Angrist | Massachusetts Institute of Technology | PLCO | Feb 8, 2023 | PLCO-1162 |
| AI Model for Predicting Outcomes in Incidences of Colorectal Cancer. | Siofra Murdoch | Harvard University | PLCO | Feb 8, 2023 | PLCO-1161 |
| Validation of a Self-Supervised Model for Tumor Recognition and Generalizability using the PLCO Cancer Screening Trial Dataset | Addie Dvir | Imagene | PLCO | Feb 8, 2023 | PLCOI-1158 |
| Other cancer incidence in PLCO | Ellen Chang | GRAIL, LLC | PLCO | Feb 8, 2023 | PLCO-1157 |
| The relationship between stroke mortality and vasectomy in men using the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial | Hui Tang | Nanchong Central Hospital,The Second Clinical College of North Sichuan Medical College | PLCO | Feb 8, 2023 | PLCO-1155 |
| A Machine Learning Model to Identify Patients at Risk for Developing Lung Cancer | Janakiraman Subramanian | Inova Health System | PLCO | Feb 8, 2023 | PLCO-1154 |
| Pilot study of air pollution adducts in PLCO serum samples | Katherine McGlynn | National Cancer Institute | PLCO | Feb 2, 2023 | 2023-9000 |
| Infection and immunity in uterine corpus and ovarian cancers | Kara Michels | Albert Einstein College of Medicine | PLCO | Feb 1, 2023 | 2022-0037 |
| Association between low-fat dairy consumption and risk of lung cancer in the PLCO Cancer Screening Trial | Ling Xiang | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Jan 23, 2023 | PLCO-1150 |
| Perfluorooctanoic acid (PFOA) exposure, DNA methylation patterns, and renal cell carcinoma | Charles Breeze | National Cancer Institute | PLCO | Jan 19, 2023 | 2022-0036 |
| Role of Cyanobacteria and cyanotoxins in liver cancer development | Brenda Hernandez | University of Hawaii Cancer Center | PLCO | Jan 19, 2023 | 2022-0033 |
| Ultra-processed food consumption and all-cause and cause-specific mortality among US cancer survivors | Guo-Chao Zhong | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Jan 18, 2023 | PLCO-1147 |
| Missing censoring indicators in survival analysis | Mikael Escobar-Bach | Laboratoire Angevin de Recherche en Mathématiques, Université d'Angers | PLCO | Jan 18, 2023 | PLCO-1149 |
| Ovarian Cancer Detection using Menstruation and Weight/Calorie Tracking | Kavin Mohan | Queen's University | PLCO | Jan 13, 2023 | PLCO-1146 |